If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.675
Bid: 18.35
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.65 (3.542%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.675
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

3 Jan 2023 15:30

RNS Number : 5561L
BATM Advanced Communications Ld
03 January 2023
 

LEI: 213800FLQUB9J289RU66

3 January 2023

 

BATM Advanced Communications Limited

("BATM" or "the Company")

 

Grant of Options

 

Further to the Company's announcements of 24 November and 21 December 2022, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that the Company granted, on 1 January 2023 (the "Grant Date"), options over ordinary shares of 0.01 NIS each in the capital of the Company ("Ordinary Shares") to certain Directors as follows:

 

Name

Role

Number of options granted

Options exercise price

Period and conditions of vesting

Gideon Chitayat*

Chairman

1,229,369

25.49 pence

The options fully vest on the first anniversary of the Grant Date.

Moti Nagar

CEO

16,433,937

25.49 pence

 

One-third of the options will vest on each of the first, second and third anniversaries of the Grant Date.

* Dr. Chitayat's options were granted to GMBS General Management & Business Strategy Consultants Ltd., a service company through which Dr. Chitayat provides his services to the Company

 

The options were granted under the BATM Advanced Communications Ltd. Global Share Incentive Plan (2021) ("SIP (2021)"). The exercise price represents the average closing price of the Company's Ordinary Shares on the London Stock Exchange over the 30 trading days preceding the Grant Date. The options granted to Mr. Nagar have a total grant value of 2% of the value of the Company on the Grant Date, as approved by shareholders at the Company's annual general meeting of 21 December 2022. Each grantee's options are exercisable subject to that grantee remaining a service provider of the Company and for 90 days thereafter.

 

Following the above option grants, Mr. Nagar and Dr. Chitayat hold options over Ordinary Shares and Restricted Share Units ("RSUs") as detailed below:

 

Instrument

Scheme

Number

Date of grant

Exercise price (if applicable)

Date of first vesting

Conditions of vesting/exercise*

Expiry date (if applicable)

Gideon Chitayat, Chairman

Options over Ordinary Shares

SIP (2021)

1,229,369

01/01/23

25.49 pence

01/01/24

The options fully vest on the first anniversary of the grant date.

01/01/33

Moti Nagar, CEO

Options over Ordinary Shares

ESOP (2004)

906,200

05/05/15

12.69 pence

31/12/16

The options are fully vested and are exercisable.

04/05/25

SIP (2021)

16,433,937

01/01/23

25.49 pence

01/01/24

The options vest equally on the first, second and third anniversaries of the date of grant.

01/01/33

Restricted Share Units

SIP (2021)

537,109

12/04/22

N/A

12/04/25

The RSUs vest on the third anniversary of the grant date subject to total shareholder return performance over the three-year period (for details, see page 56 of BATM's Annual Report 2021). If, and to the extent that, these RSUs vest, the resulting ordinary shares will be subject to a two-year holding period, however, sufficient awards may be sold during the holding period to satisfy any tax liabilities owed. 

N/A

 

* All options and RSUs are subject to the provisions of the scheme under which they were granted and are exercisable subject to the grantee remaining a service provider of the Company and for 90 days thereafter.

 

Enquiries:

 

BATM Advanced Communications

Moti Nagar, Chief Executive Officer

+972 9866 2525

 

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

+44 20 7408 4050 

 

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Gideon Chitayat

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chairman

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BATM ADVANCED COMMUNICATIONS LTD

b)

 

LEI

 

 

213800FLQUB9J289RU66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.01 NIS each

Identification code

IL0010849045

b)

 

Nature of the transaction

 

 

Grant of options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

25.49 pence

1,229,369

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

1 January 2023

 

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Moti Nagar

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BATM ADVANCED COMMUNICATIONS LTD

b)

 

LEI

 

 

213800FLQUB9J289RU66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.01 NIS each

Identification code

IL0010849045

b)

 

Nature of the transaction

 

 

Grant of options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

25.49 pence

16,433,937

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

1 January 2023

 

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLELEIVIIV
Date   Source Headline
26th Nov 202012:21 pmRNSBlock Listing Interim Review
23rd Nov 202011:58 amRNSNotice of AGM
5th Oct 20207:00 amRNSMajor new customer for COVID-19 diagnostic tests
27th Aug 20207:00 amRNSBATM secures first tier 1 customer for NFVTime
17th Aug 20207:00 amRNSInterim Results
6th Aug 20206:16 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSNotice of Results
5th Aug 20208:09 amRNSSuccessful proof-of-concept with Vodafone
15th Jul 20207:00 amRNSBATM expands COVID-19 diagnostic tests
25th Jun 20207:00 amRNSBusiness and Trading Update
4th Jun 202012:01 pmRNSHolding(s) in Company
26th May 20207:00 amRNSBlock Listing Application
6th May 202011:45 amRNSHolding(s) in Company
5th May 20207:00 amRNSBATM Launches Antibody Tests for COVID-19
30th Apr 20204:33 pmRNSAnnual Financial Report - DTR 6.3.5 Disclosure
30th Apr 20207:00 amRNSCOVID-19 Update
22nd Apr 20207:00 amRNSBATM receives c. $31m order to produce ventilators
19th Mar 20207:00 amRNSNovamed partnership for COVID-19 diagnostics kit
6th Mar 20207:00 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSFull Year Results
27th Feb 20207:00 amRNSBATM Develops Diagnostics Kit for COVID-19
24th Feb 20207:00 amRNSAward of $4m follow-on cyber contract
12th Feb 20207:00 amRNSNotice of Results
10th Feb 20207:00 amRNSThird international agri-waste contract
7th Feb 20207:00 amRNSHolding(s) in Company
23rd Jan 202011:43 amRNSHolding(s) in Company
22nd Jan 20205:54 pmRNSHolding(s) in Company
7th Jan 20207:00 amRNSFirst commercial agreement for Ador
5th Dec 20193:49 pmRNSResult of AGM
5th Dec 20197:00 amRNS$4m agri-waste treatment contract in Taiwan
7th Nov 20197:00 amRNSNotice of AGM
8th Oct 20197:00 amRNSDirector Share Purchases
7th Oct 20197:00 amRNSExpansion of cyber offering and follow-on contract
2nd Oct 20197:00 amRNSBATM completes delivery under Arm agreement
10th Sep 20197:00 amRNSDirector Shareholding, Issue of Equity and TVR
2nd Sep 20192:19 pmRNSHolding(s) in Company
23rd Aug 20197:00 amRNSBATM joins Tel-Aviv Stock Exchange indices
20th Aug 20192:34 pmRNSHolding(s) in Company
19th Aug 20197:00 amRNSInterim Results
7th Aug 201911:11 amRNSShare Option Exercise, Issue of Equity and TVR
5th Aug 20197:00 amRNSNotice of Results
31st Jul 20192:45 pmRNSReceipt of c. $3.4m from sale of IBC holding
22nd Jul 20197:00 amRNSBATM Advances 5G Strategy with New T-Metro 8104
11th Jul 20199:20 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
11th Jul 20197:45 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
8th Jul 20197:00 amRNSSecondary Listing on the Tel Aviv Stock Exchange
25th Jun 20198:28 amRNSResults of Placing and Subscription
24th Jun 20195:26 pmRNSProposed Fundraise to raise a minimum of US$15m
17th Jun 20197:00 amRNSNew solution under NXP Semiconductors partnership
10th Jun 20197:00 amRNSBATM Cyber Security Partnership with Clavister

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.